Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

A Computational Modeling of ADLumin Chemiluminescence: Oxygenation and Dioxetanone Formation

2 weeks 1 day ago
ADLumin is a new class of turn-on chemiluminescent probes that have shown increased luminescent intensity in the presence of amyloid beta ( A β $$ \mathrm{A}\beta $$ ) plaques, which are commonly associated with Alzheimer's disease (AD). ADLumin shares an imidazopyrazinone (IPO) moiety with the well-known Cypridina luciferin, which reacts with O(2) and produces bioluminescence. While the reaction mechanism for many other luciferins has been studied extensively, the chemiluminescent mechanism...
Carly Wickizer

NetMHCIIphosPan: A Machine Learning Tool for Predicting HLA Class II Antigen Presentation of Phosphorylated Peptides

2 weeks 1 day ago
Phosphorylated peptides presented by human leukocyte antigen (HLA) class II molecules play pivotal roles in immune regulation, yet their characterization and prediction remain challenging due to data noise and limited HLA coverage. Here, we introduce NetMHCIIphosPan, a prediction method for HLA-II antigen presentation of phosphorylated peptides, developed using mass spectrometry (MS)-based immunopeptidomics data sets. Employing a refined peptide identification workflow, we reanalyzed earlier...
Heli M Garcia Alvarez

Solitary Porokeratoma on the Foot: A Case Report and Literature Review

2 weeks 1 day ago
Porokeratoma (PRKT) is a rare epidermal acanthoma that can clinically resemble other hyperkeratotic or verrucous lesions, creating potential diagnostic uncertainty without histopathologic evaluation. It typically presents as a solitary exophytic lesion that lacks the annular architecture associated with other porokeratosis variants and may therefore be misclassified on clinical examination alone. We report the case of an immunocompetent 67-year-old male with a 10-week history of a progressively...
Igor Shendrik

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis

2 weeks 1 day ago
CONCLUSION: Significant improvement in MELD-Na & Fibroscan scores were observed in patients on treatment with ETV.
Bader Faiyaz Zuberi

Methodology, characterization, and multiple-path particle dosimetry modeling of laboratory inhalation exposure for micro-nanoplastic particles in rodents

2 weeks 1 day ago
Plastics are ubiquitous in all trophic environments. Human exposures primarily occur via ingestion, inhalation, and/or injection routes. However, laboratory models of micro- and nanoplastic (MNP) particle exposures replicating the human condition remain inconsistent and uncharacterized, thus limiting study strength and compromising the reliability of results. The purpose of this study was to thoroughly optimize and characterize an established methodology for MNP rodent inhalation exposures, and...
Gina M Moreno

Pagination

  • Previous page ‹ Previous
  • Page 187
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies